MedTrace Logo

Clinical Study to Evaluate the Anti-aging Efficacy of Dermial®

NCT05813054 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-08-27

No results posted yet for this study

Summary

Oral supplement with an HA matrix ingredient composed of HA (60-75%), sulfated GAGs (≥10%), including DS and CS, and collagen (≥ 5%) to evaluate the hydration of the stratum corneum of facial skin in healthy women showing natural signs of age-related aging versus placebo

Conditions

  • Skin Aging

Interventions

DIETARY_SUPPLEMENT

HA matrix ingredient

1 capsule/day

DIETARY_SUPPLEMENT

Placebo

1 capsule/day

Sponsors & Collaborators

  • Bioiberica

    lead INDUSTRY

Principal Investigators

  • Salvador Arias · Hospital Virgen de las Nieves (Granada)

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-01
Primary Completion
2023-03-15
Completion
2023-09-15

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05813054 on ClinicalTrials.gov